Table 2.
Schedules preconsolidation.
Treatment preconsolidation | Number of patients | % |
---|---|---|
R alone ×4 | 6 | 27.3 |
R-CHOP | 13 | 59.1 |
R-EPOCH | 1 | 4.5 |
R-COP | 2 | 9.1 |
| ||
Total | 22 | 100 |
R: Rituximab 375 mg/m2.
Schedules preconsolidation.
Treatment preconsolidation | Number of patients | % |
---|---|---|
R alone ×4 | 6 | 27.3 |
R-CHOP | 13 | 59.1 |
R-EPOCH | 1 | 4.5 |
R-COP | 2 | 9.1 |
| ||
Total | 22 | 100 |
R: Rituximab 375 mg/m2.